Neonatal outcomes after in-utero exposure to magnesium sulphate: a retrospective analysis

被引:0
|
作者
Mota, Ricardo Barreto [1 ]
Rey Y Formoso, Vicente [1 ]
Soares, Paulo
Guimarae, Hercilia [2 ,3 ]
机构
[1] Ctr Hosp & Univ Sao Joao, Paediat Dept, Porto, Portugal
[2] Ctr Hosp & Univ Sao Joao, Neonatal Intens Care Unit, Porto, Portugal
[3] Univ Porto, Fac Med, Porto, Portugal
关键词
Magnesium sulphate; cerebral palsy; necrotizing enterocolitis; preterm birth; persistent ductus arteriosus; MORTALITY;
D O I
10.7363/120120
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Magnesium sulphate (MgSO4) is routinely administered to pregnant women as a tocolytic and as a neuroprotective agent against cerebral palsy and motor impairment in preterm neonates. However, concerns have recently been arising regarding its effects in the neonate, including cardiovascular, intestinal, and neurological adverse effects. Our goal is to analyse prenatal MgSO4 administration and neonatal outcomes. Methods: We conducted a retrospective study that included all neonates born under 32 weeks of gestational age admitted to our Neonatal Intensive Care Unit between January 2016 and December 2019. Patients with life-threatening congenital malformations were excluded. Gestational, perinatal and outcome data were collected and statistically analysed. Results: One hundred and eighteen infants were included, of which 61 (51.7%) had been exposed to MgSO4 in utero. Mothers treated with MgSO4 were more likely also to have received corticosteroids for lung maturation and/or perinatal antibiotics. All but 5 (95.8%) infants needed post-natal resuscitation manoeuvres. Neonates that were prenatally exposed to MgSO4 were less likely to require such manoeuvres (p = 0.039), and immediate oxygen therapy (p = 0.015) was less frequently required. The median neonatal serum magnesium was higher in those exposed to MgSO4 (2.51 mEq/L) than in non-exposed (1.87 mEq/L) (p < 0.001). Neonatal serum magnesium values had a positive correlation with maternal prenatal values, with a Spearman's value of 0.78 (p < 0.001). Neonates prenatally exposed to MgSO4 were less likely to require surfactant treatment or aminergic support as well as less likely to have a persistent ductus arteriosus. No other statistically significant differences were found when comparing both groups for other outcomes. Conclusion: Prenatal exposure to MgSO4 is apparently safe for preterm infants. However, the conduction of a larger, prospective study must confirm these data.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] NEURODEVELOPMENT AFTER IN-UTERO EXPOSURE TO PHENYTOIN AND CARBAMAZEPINE
    JERET, JS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (11): : 850 - 850
  • [12] Neonatal outcomes of preterm infants with in-utero exposure to drugs of substance use: US national data
    Puthuraya, Subhash
    Karnati, Sreenivas
    Othman, Hasan
    Sripathi, Rachana
    Nandakumar, Vanishree
    Aly, Hany
    PEDIATRICS AND NEONATOLOGY, 2023, 64 (01): : 53 - 60
  • [13] A pilot study on in-utero exposure to psychotropic drugs: A comparison of pharmacological classes on neonatal and maternal outcomes
    Damer, Elvera A.
    van Kampen, Demi
    Edens, Mireille A.
    Hemels, Marieke A. C.
    Bijvank, Bas S. W. A. Nij
    ter Horst, Peter G. J.
    GENERAL HOSPITAL PSYCHIATRY, 2024, 90 : 76 - 83
  • [14] Clonidine to treat neonatal withdrawal due to in-utero venlafaxine exposure
    Rivera-Hernandez, Pedro
    Quin, Jena
    Slater-Myer, Linda
    PEDIATRICS, 2018, 142
  • [15] Poor neonatal adaptation following in-utero exposure to quetiapine and lamotrigine
    Lau, C.
    Watson, H.
    Cheong, J.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 35 (06) : 646 - 646
  • [17] Neonatal outcomes after in utero exposure to antipsychotics: a systematic review and meta-analysis
    Joseph-Delaffon, Kristen
    Eletri, Lina
    Dechartres, Agnes
    Nordeng, Hedvig Marie Egeland
    Richardson, Jonathan Luke
    Elefant, Elisabeth
    Mitanchez, Delphine
    Marin, Benoit
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2024, 39 (10) : 1073 - 1096
  • [18] Neonatal Outcomes Associated With in Utero Exposure to Oxycodone, Overall and by Trimester of Exposure: A Retrospective Cohort Study
    Kelty, Erin
    Terplan, Mishka
    Orr, Carol
    Preen, David B.
    JOURNAL OF PAIN, 2023, 24 (04): : 617 - 626
  • [19] Partially Reversible Immunodeficiency After In-Utero Exposure to Immunosuppressants
    Goessling, Katharina L.
    Kobbe, Robin
    Boetticher, Benedikt
    Soura, Stavrieta
    Borkhardt, Arndt
    Wittkowski, Helmut
    Schwab, Matthias
    Kobbe, Guido
    Neubert, Jennifer
    Ghosh, Sujal
    Laws, Hans-Juergen
    Oommen, Prasad Thomas
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2023, 120 (46): : 795 - 796
  • [20] Premenopausal breast cancer after in-utero exposure to stilboestrol
    Huckell, C
    Laskin, J
    Gelmon, K
    LANCET, 1996, 348 (9023): : 331 - 331